A Candidate Ac3-S-LPS Vaccine Against S. flexneri 1b, 2a, 3a, 6, and Y Activates Long-Lived Systemic and Mucosal Immune Responses in Healthy Volunteers: Results of an Open-Label, Randomized 2 Clinical Trial

ABSTRACT:

SUBMITTER: Ledov V 

PROVIDER: S-EPMC11945589 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature